Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Opalka

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Leukemia|January 28, 2005
Cellular in vitro immune function in multiple myeloma patients after high-dose chemotherapy and autologous peripheral stem cell transplantationM Lindemann, P Schuett, T Moritz, et al.
Blood|October 24, 1997
Detection of AML1/ETO fusion transcripts in patients with t(8;21) acute myeloid leukemia after allogeneic bone marrow transplantation or peripheral blood progenitor cell transplantationA H Elmaagacli, D W Beelen, J Stockova, et al.
Blood|November 1, 1991
Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon alpha-2b alone or in combination with interferon gammaB Opalka, U B Wandl, R Becher, et al.
British Journal of Urology|April 1, 1996
Genetic instability of 3p12-p21-specific microsatellite sequences in renal cell carcinomaC P Willers, R Siebert, W Bardenheuer, et al.
Human Genetics|July 1, 1997
Identification of novel 'expressed sequence tags' within the FHIT gene locus in human chromosome region 3p14.2A Lux, W Bardenheuer, D Michael, et al.
Journal of the National Cancer Institute|September 24, 1999
Novel tumor suppressor locus in human chromosome region 3p14.2K Jülicher, G Marquitan, N Werner, et al.
Genes, Chromosomes & Cancer|January 27, 1998
Minimal deletion of 3p13-->14.2 associated with immortalization of human uroepithelial cellsL Vieten, C D Belair, L Savelieva, et al.
Bone Marrow Transplantation|August 1, 1996
Molecular studies of chimerism and minimal residual disease after allogeneic peripheral blood progenitor cell or bone marrow transplantationA H Elmaagacli, D W Beelen, H W Becks, et al.
European Journal of Haematology|February 1, 1992
A prospective randomized comparison of single-agent interferon (IFN)-alpha with the combination of IFN-alpha and low-dose IFN-gamma in chronic myelogenous leukaemiaO Kloke, U Wandl, B Opalka, et al.
British Journal of Haematology|October 1, 1995
Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell linesR Siebert, C P Willers, A Schramm, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Leukemia|January 28, 2005
Cellular in vitro immune function in multiple myeloma patients after high-dose chemotherapy and autologous peripheral stem cell transplantationM Lindemann, P Schuett, T Moritz, et al.
Blood|October 24, 1997
Detection of AML1/ETO fusion transcripts in patients with t(8;21) acute myeloid leukemia after allogeneic bone marrow transplantation or peripheral blood progenitor cell transplantationA H Elmaagacli, D W Beelen, J Stockova, et al.
Blood|November 1, 1991
Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon alpha-2b alone or in combination with interferon gammaB Opalka, U B Wandl, R Becher, et al.
British Journal of Urology|April 1, 1996
Genetic instability of 3p12-p21-specific microsatellite sequences in renal cell carcinomaC P Willers, R Siebert, W Bardenheuer, et al.
Human Genetics|July 1, 1997
Identification of novel 'expressed sequence tags' within the FHIT gene locus in human chromosome region 3p14.2A Lux, W Bardenheuer, D Michael, et al.
Journal of the National Cancer Institute|September 24, 1999
Novel tumor suppressor locus in human chromosome region 3p14.2K Jülicher, G Marquitan, N Werner, et al.
Genes, Chromosomes & Cancer|January 27, 1998
Minimal deletion of 3p13-->14.2 associated with immortalization of human uroepithelial cellsL Vieten, C D Belair, L Savelieva, et al.
Bone Marrow Transplantation|August 1, 1996
Molecular studies of chimerism and minimal residual disease after allogeneic peripheral blood progenitor cell or bone marrow transplantationA H Elmaagacli, D W Beelen, H W Becks, et al.
European Journal of Haematology|February 1, 1992
A prospective randomized comparison of single-agent interferon (IFN)-alpha with the combination of IFN-alpha and low-dose IFN-gamma in chronic myelogenous leukaemiaO Kloke, U Wandl, B Opalka, et al.
British Journal of Haematology|October 1, 1995
Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell linesR Siebert, C P Willers, A Schramm, et al.
Pageof 7